Cargando…
Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model
BACKGROUND: Mesenchymal stem cells (MSCs) can improve limb perfusion and increase vessel density in a murine model of hindlimb ischemia. But low engraftment rate of those cells limited their therapeutic effect. Endothelial cells (ECs) play an important role in neovascularization. And MSCs can differ...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278145/ https://www.ncbi.nlm.nih.gov/pubmed/32513272 http://dx.doi.org/10.1186/s13287-020-01710-x |
_version_ | 1783543274318856192 |
---|---|
author | Yao, Ziping Liu, Huihui Yang, Min Bai, Yun Zhang, Bihui Wang, Chengen Yan, Ziguang Niu, Guochen Zou, Yinghua Li, Yuan |
author_facet | Yao, Ziping Liu, Huihui Yang, Min Bai, Yun Zhang, Bihui Wang, Chengen Yan, Ziguang Niu, Guochen Zou, Yinghua Li, Yuan |
author_sort | Yao, Ziping |
collection | PubMed |
description | BACKGROUND: Mesenchymal stem cells (MSCs) can improve limb perfusion and increase vessel density in a murine model of hindlimb ischemia. But low engraftment rate of those cells limited their therapeutic effect. Endothelial cells (ECs) play an important role in neovascularization. And MSCs can differentiate into ECs in vitro. The aim of this study is to investigate if EC differentiation of MSCs in vitro before transplantation is effective in improving therapeutic outcomes in the treatment of ischemic disease in a murine ischemia animal model. METHODS: MSCs were isolated from the bone marrow of EGFP-transgenic mice by density gradient centrifugation. The identity of the MSCs was determined by their cluster of differentiation (CD) marker profile by flow cytometry. Inducing medium containing a few cytokines was applied to induce the MSCs to differentiate into ECs. Endothelial differentiation was quantitatively evaluated using flow cytometry, quantitative real-time PCR (qRT-PCR), immunofluorescence, Matrigel tube formation assay, and Dil-labeled acetylated low-density lipoprotein uptake assay. Mouse hindlimb ischemia model was made by excision of the femoral artery. Uninduced EGFP+ MSCs, induced EGFP+ MSCs, and PBS were intramuscularly injected into the gastrocnemius following ischemia no later than 24 h after operation. Restoration of blood flow and muscle function was evaluated by laser Doppler perfusion imaging. Immunofluorescence was conducted to evaluate the engraftment of transplanted MSCs. Histological analysis was performed to evaluate blood vessel formation. RESULTS: Induced EGFP+ MSCs expressed endothelial markers and exhibited tube formation capacity. Mice in the induced EGFP+ MSCs group had a better blood perfusion recovery, enhanced vessel densities, higher engraftment, and improved function of the ischemic limb than those in the uninduced EGFP+ MSCs or PBS groups. CONCLUSIONS: This study reveals that after short-term pre-treatment in the EC-inducing medium, induced MSCs acquire stronger vessel formation capability and enhanced angiogenic therapeutic effect in the murine hindlimb ischemia model. |
format | Online Article Text |
id | pubmed-7278145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72781452020-06-09 Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model Yao, Ziping Liu, Huihui Yang, Min Bai, Yun Zhang, Bihui Wang, Chengen Yan, Ziguang Niu, Guochen Zou, Yinghua Li, Yuan Stem Cell Res Ther Research BACKGROUND: Mesenchymal stem cells (MSCs) can improve limb perfusion and increase vessel density in a murine model of hindlimb ischemia. But low engraftment rate of those cells limited their therapeutic effect. Endothelial cells (ECs) play an important role in neovascularization. And MSCs can differentiate into ECs in vitro. The aim of this study is to investigate if EC differentiation of MSCs in vitro before transplantation is effective in improving therapeutic outcomes in the treatment of ischemic disease in a murine ischemia animal model. METHODS: MSCs were isolated from the bone marrow of EGFP-transgenic mice by density gradient centrifugation. The identity of the MSCs was determined by their cluster of differentiation (CD) marker profile by flow cytometry. Inducing medium containing a few cytokines was applied to induce the MSCs to differentiate into ECs. Endothelial differentiation was quantitatively evaluated using flow cytometry, quantitative real-time PCR (qRT-PCR), immunofluorescence, Matrigel tube formation assay, and Dil-labeled acetylated low-density lipoprotein uptake assay. Mouse hindlimb ischemia model was made by excision of the femoral artery. Uninduced EGFP+ MSCs, induced EGFP+ MSCs, and PBS were intramuscularly injected into the gastrocnemius following ischemia no later than 24 h after operation. Restoration of blood flow and muscle function was evaluated by laser Doppler perfusion imaging. Immunofluorescence was conducted to evaluate the engraftment of transplanted MSCs. Histological analysis was performed to evaluate blood vessel formation. RESULTS: Induced EGFP+ MSCs expressed endothelial markers and exhibited tube formation capacity. Mice in the induced EGFP+ MSCs group had a better blood perfusion recovery, enhanced vessel densities, higher engraftment, and improved function of the ischemic limb than those in the uninduced EGFP+ MSCs or PBS groups. CONCLUSIONS: This study reveals that after short-term pre-treatment in the EC-inducing medium, induced MSCs acquire stronger vessel formation capability and enhanced angiogenic therapeutic effect in the murine hindlimb ischemia model. BioMed Central 2020-06-08 /pmc/articles/PMC7278145/ /pubmed/32513272 http://dx.doi.org/10.1186/s13287-020-01710-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yao, Ziping Liu, Huihui Yang, Min Bai, Yun Zhang, Bihui Wang, Chengen Yan, Ziguang Niu, Guochen Zou, Yinghua Li, Yuan Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model |
title | Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model |
title_full | Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model |
title_fullStr | Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model |
title_full_unstemmed | Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model |
title_short | Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model |
title_sort | bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278145/ https://www.ncbi.nlm.nih.gov/pubmed/32513272 http://dx.doi.org/10.1186/s13287-020-01710-x |
work_keys_str_mv | AT yaoziping bonemarrowmesenchymalstemcellderivedendothelialcellsincreasecapillarydensityandaccelerateangiogenesisinmousehindlimbischemiamodel AT liuhuihui bonemarrowmesenchymalstemcellderivedendothelialcellsincreasecapillarydensityandaccelerateangiogenesisinmousehindlimbischemiamodel AT yangmin bonemarrowmesenchymalstemcellderivedendothelialcellsincreasecapillarydensityandaccelerateangiogenesisinmousehindlimbischemiamodel AT baiyun bonemarrowmesenchymalstemcellderivedendothelialcellsincreasecapillarydensityandaccelerateangiogenesisinmousehindlimbischemiamodel AT zhangbihui bonemarrowmesenchymalstemcellderivedendothelialcellsincreasecapillarydensityandaccelerateangiogenesisinmousehindlimbischemiamodel AT wangchengen bonemarrowmesenchymalstemcellderivedendothelialcellsincreasecapillarydensityandaccelerateangiogenesisinmousehindlimbischemiamodel AT yanziguang bonemarrowmesenchymalstemcellderivedendothelialcellsincreasecapillarydensityandaccelerateangiogenesisinmousehindlimbischemiamodel AT niuguochen bonemarrowmesenchymalstemcellderivedendothelialcellsincreasecapillarydensityandaccelerateangiogenesisinmousehindlimbischemiamodel AT zouyinghua bonemarrowmesenchymalstemcellderivedendothelialcellsincreasecapillarydensityandaccelerateangiogenesisinmousehindlimbischemiamodel AT liyuan bonemarrowmesenchymalstemcellderivedendothelialcellsincreasecapillarydensityandaccelerateangiogenesisinmousehindlimbischemiamodel |